Skip to content
10-Q

Quarterly Report

SPECTRUM PHARMACEUTICALS INC

0000831547-23-000012

← back to feed
Filed
May 11, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 9, 2023 205.26M sh
Shares Diluted Q1 2023 · Mar 31, 2023 201.92M sh
Shares Diluted Q1 2023 · Mar 31, 2022 169.74M sh
Capex Q1 2023 · Mar 31, 2023 $108K
Capex Q1 2023 · Mar 31, 2022 $39K
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$21.44M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$30.3M
Long Term Debt Q1 2023 · Mar 31, 2023 $28.84M
Short Term Investments Q1 2023 · Mar 31, 2023 $3.76M
Short Term Investments Q1 2023 · Dec 31, 2022 $34.73M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $52.37M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $40.37M
Stockholders Equity Q1 2023 · Mar 31, 2023 $26.81M
Stockholders Equity Q1 2023 · Dec 31, 2022 $27.89M
Stockholders Equity Q1 2023 · Mar 31, 2022 $55.26M
Stockholders Equity Q1 2023 · Dec 31, 2021 $47.55M
Current Liabilities Q1 2023 · Mar 31, 2023 $38.88M
Current Liabilities Q1 2023 · Dec 31, 2022 $42.69M
Total Liabilities Q1 2023 · Mar 31, 2023 $80.87M
Total Liabilities Q1 2023 · Dec 31, 2022 $75.45M
Current Assets Q1 2023 · Mar 31, 2023 $105.38M
Current Assets Q1 2023 · Dec 31, 2022 $101.01M
Total Assets Q1 2023 · Mar 31, 2023 $107.68M
Total Assets Q1 2023 · Dec 31, 2022 $103.34M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.02
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.09
Eps Basic Q1 2023 · Mar 31, 2023 −$0.02
Eps Basic Q1 2023 · Mar 31, 2022 −$0.09
Sga Expense Q1 2023 · Mar 31, 2023 $14M
Sga Expense Q1 2023 · Mar 31, 2022 $9.87M
Rd Expense Q1 2023 · Mar 31, 2023 $5.42M
Rd Expense Q1 2023 · Mar 31, 2022 $4.19M
Net Income Q1 2023 · Mar 31, 2023 −$5.01M
Net Income Q1 2023 · Mar 31, 2022 −$15.44M
Operating Income Q1 2023 · Mar 31, 2023 −$4.87M
Operating Income Q1 2023 · Mar 31, 2022 −$14.06M
Revenue Q1 2023 · Mar 31, 2023 $15.62M
Revenue Q1 2023 · Mar 31, 2022 $0